Abstract:Cerebrovascular reactivity (CVR), the ability of cerebral blood vessels to dilate or constrict in order to regulate blood flow, is a clinically useful measure of cerebrovascular health. CVR is often measured using a breath-hold task to modulate blood CO levels during an fMRI scan. Measuring end-tidal CO (P CO ) with a nasal cannula during the task allows CVR amplitude to be calculated in standard units (vascular response per unit change in CO , or %BOLD/mmHg) and CVR delay to be calculated in seconds. The use of standard units allows for normative CVR ranges to be established and for CVR comparisons to be made across subjects and scan sessions. Although breath-holding can be successfully performed by diverse patient populations, obtaining accurate P CO measurements requires additional task compliance; specifically, participants must breathe exclusively through their nose and exhale immediately before and after each breath hold. Meeting these requirements is challenging, even in healthy participants, and this has limited the translational potential of breath-hold fMRI for CVR mapping. Previous work has focused on using alternative regressors such as respiration volume per time (RVT), derived from respiratory belt measurements, to map CVR. Because measuring RVT does not require additional task compliance from participants, it is a more feasible measure than P CO However, using RVT does not produce CVR in standard units. In this work, we explored how to achieve CVR maps, in standard units, when breath-hold task P CO data quality is low. First, we evaluated whether RVT could be scaled to units of mmHg using a subset of P CO data of sufficiently high quality. Second, we explored whether a P CO timeseries predicted from RVT using deep learning allows for more accurate CVR measurements. Using a dense-mapping breath-hold fMRI dataset, we showed that both rescaled RVT and rescaled, predicted P CO can be used to produce maps of CVR amplitude and delay in standard units with strong absolute agreement to ground-truth maps. However, the rescaled, predicted P CO regressor resulted in superior accuracy for both CVR amplitude and delay. In an individual with regions of increased CVR delay due to Moyamoya disease, the predicted P CO regressor also provided greater sensitivity to pathology than RVT. Ultimately, this work will increase the clinical applicability of CVR in populations exhibiting decreased task compliance.

Detection of the Cerebrovascular Reactivity

Assessment of Cerebrovascular Reactivity Using CO2-BOLD MRI: A 15-Year, Single Center Experience

Intracerebral Reserve Assessment with SPECT: Reactivity to Acetazolamide and Cerebral Blood Volume Measurement

Magnetic resonance imaging for assessment of cerebrovascular reactivity and its relationship to cognition: a systematic review

Reproducibility of cerebrovascular reactivity measurements: A systematic review of neuroimaging techniques*

Magnetic resonance imaging for cerebrovascular reactivity assessment

Abstract W MP71: Quantification of Cerebral Vascular Reserve Mapping from Dynamic Susceptibility Contrast Magnetic Resonance Imaging

Quantitative mapping of cerebrovascular reactivity amplitude and delay with breath-hold BOLD fMRI when end-tidal CO quality is low

[Cerebrovascular reserve capacity]

Agreement in cerebrovascular reactivity assessed with diffuse correlation spectroscopy across experimental paradigms improves with short separation regression

CVR-MRICloud: An online processing tool for CO2-inhalation and resting-state cerebrovascular reactivity (CVR) MRI data

Evaluation of Cerebrovascular Reserve by Xenon Computed Tomography in Patients with Ischemic Stroke

Transcranial Doppler cerebrovascular reactivity: Thresholds for clinical significance in cerebrovascular disease

Cerebrovascular reactivity dispersion as a new biomarker of recent stroke symptomatology in moyamoya

Investigating the non-linearity of the BOLD cerebrovascular reactivity response to targeted hypo/hypercapnia at 7T

Bayesian Modelling Approaches for Breath-Hold Induced Cerebrovascular Reactivity

The novel imaging methods in diagnosis and assessment of cerebrovascular diseases: an overview

Estimation of cerebrovascular reactivity amplitude and lag using breath-holding fMRI and the global BOLD signal: Application in diabetes and hypertension

Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing

Evaluating Methods for Cerebrovascular Autoregulation and the Clinical Applications (Review)

Cerebral hemodynamics in acute stroke: pathophysiology and clinical implications